Jacobs Levy Equity Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Jacobs Levy Equity Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-39,267	Closed	-$204K	–	1098
2016 Q4	$204K	Sell	39,267 -36,805	-48%	-$173K	﹤0.01%	834
2016 Q3	$355K	Sell	76,072 -16,300	-18%	-$76.1K	0.01%	776
2016 Q2	$364K	Sell	92,372 -24,899	-21%	-$93K	0.01%	838
2016 Q1	$364K	Buy	117,271 +73,911	+170%	+$248K	0.01%	815
2015 Q4	$198K	Buy	43,360 +28,160	+185%	+$134K	﹤0.01%	697
2015 Q3	$72K	Buy	+15,200	New	+$98.1K	﹤0.01%	779

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Jacobs Levy Equity Management's DSCI Position: Q1 2017 in Review

Jacobs Levy Equity Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 39,267 shares — an estimated $204K sold.

Jacobs Levy Equity Management first reported a position in DSCI in Q3 2015 and held it in 6 quarters. The position peaked at $364K in Q2 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Jacobs Levy Equity Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Jacobs Levy Equity Management sold 39,267 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $204K.
Jacobs Levy Equity Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2015 and held it in 6 quarters.
Jacobs Levy Equity Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $364K in Q2 2016.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.